U.S. FDA warns GSK over problems at Quebec flu vaccine manufacturing plant

The company that makes much of Canada’s annual flu vaccine and has the country’s pandemic flu vaccine contract has been issued a warning from the U.S. Food and Drug Administration.

TORONTO — The company that makes much of Canada’s annual flu vaccine and has the country’s pandemic flu vaccine contract has been issued a warning from the U.S. Food and Drug Administration.

The letter, dated June 12, laid out a number of concerns, many related to sterility issues and microbial contamination problems at the GSK manufacturing facility in Ste. Foy, Que. The problems were identified during an FDA inspection of the plant from March 31 to April 9.

The U.S. regulatory agency noted that since 2011 multiple batches of flu vaccine from the Quebec plant have been rejected. It warned that if the problems identified are not fixed promptly the company’s licence to produce flu vaccine for the U.S. market could be suspended or revoked.

“The deficiencies described … at the close of the inspection referenced above and this letter are an indication of your quality control unit not fulfilling its responsibility to assure the identity, strength, quality, and purity of your licensed biological drug product and intermediates,” the letter stated.

“You should take prompt action to correct these deviations. Failure to promptly correct these deviations may result in regulatory action without further notice. Such actions may include license suspension and-or revocation.”

Health Canada, which licenses vaccines in this country, said it is aware of the situation and is working closely with the company and the FDA on the matter.

In an emailed response to questions, the department said Canada has flu vaccine purchasing contracts with a number of other suppliers and can source additional vaccine from them if the need arises.

The FDA letter said the Quebec facility deviates from current good manufacturing practice requirements, the industry standards enforced by licensing agencies.

It raised concerns about the purified water system at the plant and gave the company 15 working days in which to address the problems. If problems cannot be fixed within that time frame, the company must write to explain the delay.

The agency also asked for a meeting with senior management of both GSK and the Quebec facility to discuss the identified problems and the proposed solutions.

In a written statement GSK said the company is making progress toward addressing the FDA’s concerns and is committed to working with the regulatory agency to fully resolve all outstanding issues.

Just Posted

Red Deer city council aims to force larger non-profits to become more accountable

New bylaw defines which not-for-profits must pay for a business licence

Red Deer city council will seek public input on portable signage March 4

Council gave initial approval to retaining 100-metre separation distance

Smaller, more affordable, lots wanted in Red Deer’s Evergreen neighbourhood

Council approves first reading of requested lot-size changes

RDC’s new name to be unveiled in February

The next big milestone for Red Deer College is a new name,… Continue reading

Lacombe considering licensing cats

Council is expected to take a look at cat potential licensing regulations next month

2-for-1: Total lunar eclipse comes with supermoon bonus

On Sunday night, the moon, Earth and sun lined up to create the eclipse, which was visible throughout North and South America

Opinion: Faith in immigration must be preserved

Canada has a deserved reputation for extending its arms to newcomers, but… Continue reading

Olympian Adam van Koeverden wins federal Liberal nomination in Ontario riding

MILTON, Ont. — Former Olympic flag-bearer Adam van Koeverden will be carrying… Continue reading

World champion Osmond says it’s “really nice” not to know what future holds

SAINT JOHN, N.B. — Kaetlyn Osmond has a world title, Olympic medals… Continue reading

World economy forecast to slow in 2019 amid trade tensions

For Canada, the IMF’s estimate for growth in 2019 was 1.9 per cent, down from expected global growth of 3.5 per cent

Timberlake pops in on patients at Texas children’s hospital

DALLAS — Justin Timberlake has pulled some sunshine from his pocket for… Continue reading

UK police speak to Prince Philip about not wearing seatbelt

LONDON — British police have spoken with Prince Philip after the husband… Continue reading

‘Gotti’ leads Razzie nominations, Trump up for worst actor

The nominations were announced on Monday, Jan. 21 with some movies earning up to six nominations

Curtain rising Sunday night on total lunar eclipse

CAPE CANAVERAL, Fla. — The celestial curtain will be rising soon on… Continue reading

Most Read